Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Amynova Polymers GmbH has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is handled by 1 distinct examiner and is located within 1 distinct art unit. Such a focused profile suggests that the company's current patenting activity is concentrated on a specific polymer application or a biotechnology innovation.
The busiest examiner, KIM, DANIELLE A, is responsible for 1 busiest examiner pending office action. As the total number of pending office actions for Amynova Polymers GmbH is also 1, this examiner is the individual currently reviewing the company's applications. The progress of the portfolio is therefore directly linked to the prosecution of this pending office action under this specific examiner.
The involvement of only the distinct art unit indicates a lack of technical dispersion in the current workload. Practitioners can focus their strategy on the distinct examiner, KIM, DANIELLE A, to resolve the outstanding office action. This centralized data point means that the company's immediate success in the Biotechnology & Pharmaceuticals sector depends on a successful negotiation within the USPTO.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, DANIELLE A | 1 | 37.1% | +56.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907149 | BIOCOMPATIBLE CARRIER FORMULATION FOR APPLICATIONS IN PLANT PROTECTION AND PLANT GROWTH STIMULATION OR IN COSMETICS AND PERSONAL CARE ON THE BASIS OF MODIFIED STARCH | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17907149 | BIOCOMPATIBLE CARRIER FORMULATION FOR APPLICATIONS IN PLANT PROTECTION AND PLANT GROWTH STIMULATION OR IN COSMETICS AND PERSONAL CARE ON THE BASIS OF MODIFIED STARCH | KIM, DANIELLE A | 1614 | §103 | Final Rejection | — | Pending | Sep 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial